ArticleJournal of translational medicine2021

Inhibition of CPT1a as a prognostic marker can synergistically enhance the antileukemic activity of ABT199.

Shihui Mao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.